Navidea Biopharmaceuticals Inc. (NAVB) surged 27.27% or 0.03 to $0.14. It is approximately 244021 shares traded, which is 40.4% compare to the average total volume 603968. The market cap of NAVB is $25.46 million. The year to date change is -44.45%. The 52 week price range is from $0.11 to $0.42. Price of NAVB have changed -15.38% during last week. It have changed -47.62% over last month, -55.72% over last 3 months, -51.86% over last 6 months and -72.49% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for NAVB is 0.21. It is 50.00% above current price. The 200-day Moving Averages for NAVB is 0.24. It is 71.43% above current price. The 52-week High is 0.42. It is 200.00% from the current price. The 52-week Low is 0.11. It is -21.43% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of NAVB is 15.67 on 2018-11-30. Short % to float is 3.05%. There are some statistics of NAVB. It is has market cap $25.46 million. The share outstanding is 181.89 million. The average volume is 603968. The percent of top 15 Institution holding is 9.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of NAVB is -203.88%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of NAVB is -107.28%.